Biocitech, the Parisian life sciences technology park, today announced the installation of a new firm, OCT Santé, on its campus. OCT Santé is the 25th company to relocate to Biocitech, where the occupation rate is now over 90 per cent.
The installation of this new tenant not only confirms the park’s success but also enables Biocitech to expand the range of services it offers to the biopharmaceutical industry downstream from its medical research-and-development activities. These services now include the transport of biologicals in optimum conditions and the development of packaging methods that comply with current standards.